World Sight Day: Time for Canadians to take action in the global effort to eliminate avoidable blindness

NEXT STORY
Global Point of Care (POC) Diagnostics Market Trends 2017-2019, and CAGR Projections to 2023
PREV STORY
2019 Italian Molecular Diagnostic Analyzers and Reagent Forecasts for 100 Tests: Supplier Shares, Volume and Sales Segment Forecasts, Emerging Technologies, Instrumentation Review
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

G1 Therapeutics Announces Publication of Pooled Results from Pivotal Clinical Program of COSELA™ (trilaciclib) in Clinical Lung Cancer

author_avatar
NASDAQ Market News

POAI Subsidiary Helomics Continues Progress Towards Goal of Developing an AI-Driven Predictive Model of Ovarian Cancer

author_avatar
NASDAQ Market News

FDA grants Breakthrough Therapy Designation for Roche’s Tecentriq in combination with Avastin as first-line treatment for advanced or metastatic hepatocellular carcinoma (HCC)

Basel, 18 July 2018 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that ...

author_avatar
NASDAQ Market News